[1] Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology, 2012, 55: 2005-2023.
[2] Watanabe S, Hashimoto E, Ikejima K, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Hepatol Res, 2015, 45: 363-377.
[3] 常彬霞,邹正升,李保森,等. 2015年日本胃肠病学会非酒精性脂肪性肝病/非酒精性脂肪性肝炎的循证医学临床治疗指南. 临床肝胆病杂志, 2015, 31: 1027-1030.
[4] 朱鹏, 徐宗, 王宇明. 世界胃肠病学会全球指南:非酒精性脂肪性肝病及非酒精性脂肪性肝炎. 临床肝胆病杂志, 2014,30:842-845.
[5] 范建高, 庄辉, 黄薏. 全球首部“科普版”《脂肪肝防治指南》10大关键词(一). 肝博士, 2015,2:15-21.
[6] Day CP. From fat to inflammation. Gastroenterology, 2006, 130: 207-210.
[7] Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol, 2009, 50: 204-210.
[8] Tessari P, Coracina A, Cosma A,et al. Hepatic lipid metabolism and non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis, 2009, 19: 291-302.
[9] Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci, 2010, 55: 560-578.
[10] Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med, 2012, 52: 59-69.
[11] 范建高. 脂肪性肝病. 北京:人民卫生出版社, 2005.
[12] 谢萍, 周新喜, 张琴. 祛脂三味方结合温针治疗脂肪性肝病70例临床观察. 上海中医药杂志, 2010, 44: 27-29.
[13] 许佳年,张琴,谢萍,等.针药结合治疗脂肪性肝病的临床观察. 上海中医药杂志, 2011, 45: 55-57.
[14] 张毅明,张琴,许佳年,等.针药并用治疗脂肪肝疗效观察. 上海针灸杂志, 2011,30: 291-292.
[15] 曹亚丽.无黄疸型肝炎证治-秦伯未治疗肝病经验.中国社区医师, 2007, 23: 31-32.
[16] Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology, 2001, 120: 1183-1192.
[17] Nobili V, Pastore A, Gaeta LM, et al. Glutathione Metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis. Clinica chimica acta, 2005, 355: 105-111.
[18] Adinolfi LE, Utili R, Andreana A, et al. Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C. DigDis Sci, 2001, 46: 1677-1683. |
